Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 29, 2024World Journal of Surgical OncologyOpen Access

Axillary management and long-term oncologic outcomes in breast cancer patients with clinical N1 disease treated with neoadjuvant chemotherapy

View Full Paper
Ask AI
Bookmark
Share

Authors

CSCourtney C. SpargerAHAlexandra E HernandezKRKristin E. Rojas

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Sparger et al. (2024) studied this question.

synapsesocial.com/papers/68e5eb36b6db6435875800a5https://doi.org/10.1186/s12957-024-03477-4
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The Impact of Neoadjuvant Chemotherapy on Axillary Surgical Management of Patients With Breast Cancer and Positive Axillary Lymph Nodes2024 · 3 citations
  2. 2De-Escalation of Axillary Surgery in Clinically Node-Positive Breast Cancer Patients Treated with Neoadjuvant Therapy: Comparative Long-Term Outcomes of Sentinel Lymph Node Biopsy versus Axillary Lymph Node Dissection2024 · 26 citations
  3. 3The Role of Axillary Lymph Node Dissection in Breast Cancer Patients With Residual Nodal Disease After Receiving Neoadjuvant Chemotherapy2025
  4. 4Factors Associated with Omission of Axillary Lymph Node Dissection for Patients with Clinical Node-Positive Breast Cancer Who have Residual Nodal Disease on Pathology After Neoadjuvant Chemotherapy2026 · 1 citations
  5. 5Abstract PS2-01-15: Long-term outcomes of sentinel lymph node biopsy alone for breast cancer with residual axillary nodal disease (ypN+) following neoadjuvant chemotherapy: a systematic review and meta-analysis2026